L-glutamine (Endari)

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

Pharmaceutical grade L-glutamine

Diseases for which it is used

History of changes in FDA indication

  • 7/7/2017: Approved for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Also known as

  • Brand name: Endari